| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of HS3ST1 mRNA | increases expression | 19933214
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HS3ST1 mRNA | affects expression | 16483693
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of HS3ST1 mRNA | decreases expression | 20064835
|
| D003345 |
Corticosterone |
Corticosterone results in increased expression of HS3ST1 mRNA | increases expression | 15755911
|
| C014347 |
decitabine |
decitabine results in increased expression of HS3ST1 mRNA | increases expression | 15251184
|
| C014347 |
decitabine |
[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of HS3ST1 mRNA | affects cotreatment|increases expression | 15251184
|
| D004281 |
Docosahexaenoic Acids |
PPARA protein promotes the reaction [Docosahexaenoic Acids results in increased expression of HS3ST1 mRNA] | increases expression|increases reaction | 18489776
|
| D004317 |
Doxorubicin |
HS3ST1 mRNA affects the susceptibility to Doxorubicin | affects response to substance | 16044152
|
| D015118 |
Eicosapentaenoic Acid |
PPARA protein promotes the reaction [Eicosapentaenoic Acid results in increased expression of HS3ST1 mRNA] | increases expression|increases reaction | 18489776
|
| D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in increased expression of HS3ST1 mRNA | increases expression | 16823509
|
| D043371 |
Fatty Acids, Omega-6 |
Fatty Acids, Omega-6 results in increased expression of HS3ST1 mRNA | increases expression | 16823509
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of HS3ST1 mRNA | affects cotreatment|increases expression | 15251184
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of HS3ST1 mRNA | increases expression | 19933214
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of HS3ST1 mRNA | increases expression | 19490992
|
| C034028 |
vanadyl sulfate |
vanadyl sulfate results in increased expression of HS3ST1 mRNA | increases expression | 16330358
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 11752688 15322242 14514962 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.54 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.54 | 17418594 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.71 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.67 | 21441931 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
9.51 | 18448859 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-6 |
9.51 | 18448859 |
| MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
3.05 | 18582451 |
| MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
3.05 | 16920077 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.87 | 14601052 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.91 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.97 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.97 | 19208741 18320071 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.97 | 16264153 18382427 19526202 15993339 16096432 17426702 15939500 15567936 15136595 16935488 18695136 15634643 18628466 16322301 16595493 15668708 17369602 15994142 11325840 15692762 16115903 18234424 17983394 16826403 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.98 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.24 | 18059187 16023760 17876044 16234567 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.20 | 1485588 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.76 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.76 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.76 | 6189445 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 18670907 16120746 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.60 | 17924179 17329180 17974986 17131338 16455267 17519947 15811867 17308081 17928571 17351982 17382496 16269455 16242529 15476868 16278810 16364871 16612575 16651473 15792986 18627295 16952015 16109756 17007740 15505089 16731534 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 16243910 17334414 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 8697196 15340226 15668235 12621046 16354765 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.35 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.71 | 18981723 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.71 | 18802399 18259882 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
| MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
4.77 | 19747007 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
4.46 | 16684804 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.97 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.97 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.38 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.38 | 11462148 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.29 | 19294695 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.52 | 17359293 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.33 | 18037988 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.74 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.42 | 17150277 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
8.20 | 19215824 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.20 | 15692506 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.63 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.63 | 10048152 11294989 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.56 | 16244371 16879835 16330681 18006777 17888722 16495754 18674790 16244372 16707910 14766674 16144979 17875725 12587719 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.41 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.01 | 15692506 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 12621046 16120746 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.50 | 17606976 18501091 15147373 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 16959395 15340226 18606429 8697196 16354765 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.27 | 17581917 |
| MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
5.66 | 17296493 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.66 | 12878042 12200463 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.11 | 15369732 16775033 15699352 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.26 | 16707910 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.12 | 19235587 18980019 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.33 | 16085563 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
5.11 | 17077332 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.11 | 18454857 19117987 17236224 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.39 | 18704418 18460780 19387464 19010910 18206229 17679729 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.64 | 18055864 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.46 | 16595196 16439617 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.46 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
3.43 | 17056761 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.45 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.45 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.13 | 16842330 17085340 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.13 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.46 | 17053015 18569708 18520028 20464547 6695378 20064080 20135361 18816296 20869020 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.46 | 17418594 6189445 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.46 | 11884234 19555203 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
7.99 | 19470736 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.99 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.88 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.70 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
6.74 | 12807724 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.74 | 15458769 |
| MESH:D008545 |
Melanoma |
|
decitabine |
3.60 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.60 | 16827129 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.10 | 17638057 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.61 | 15792986 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.94 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.42 | 18172295 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.44 | 19010910 16882708 18608210 19157545 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.99 | 19429709 15857846 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.99 | 18259882 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.27 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.27 | 17925555 19116145 19470736 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.91 | 16636307 16899518 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.10 | 15640375 16889571 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.31 | 15555623 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.20 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.68 | 19331143 19259094 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.80 | 19294695 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.33 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.33 | 17638057 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11222880 11896295 11399792 11118676 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.87 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.25 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.25 | 16888761 15897917 16868541 16729912 15749863 18437689 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.36 | 17922066 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.52 | 19155313 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.09 | 17203757 16767912 15675481 15625365 18313854 17710206 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.37 | 16326096 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.94 | 17846226 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.71 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.71 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.71 | 16192470 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.70 | 15625365 17203757 16767912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.60 | 20155912 2093021 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.60 | 19037991 |
| MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
3.60 | 19015929 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.70 | 17967635 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.70 | 16010429 17909728 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.62 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.62 | 17616700 19087683 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.62 | 17653716 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.09 | 17785578 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.36 | 17334414 16364871 17678736 17638931 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |